Arbutus Biopharma Corporation (ABUS)
Market Closed
16 Oct, 08:00 PM
$
4. 22
-0.07
-1.6317%
$
833.61M Market Cap
- P/E Ratio
- Div Yield
4.54M Volume
-0.45 Eps
$ 4.29
Previous Close Want to track ABUS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Arbutus Biopharma Corporation (ABUS) Statistics
Valuation metrics
Market Cap 833.61M
Enterprise value 820.46M
Trailing P/E (ttm) 5.34
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 4.6
Price/Book (mrq) 3.22
Enterprise Value/Revenue 4.51
Enterprise Value/EBITDA 5.36
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.48M
Average volume (90 days) 4.81M
Price summary
52-Week low 3.5
52-Week high 5.45
Beta -
50-Day moving average 4.78
200-Day moving average 4.58
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:5
Last split Date 4 Nov 2010
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.84%
Operating margin 0.81%
Operational effectiveness
Return on assets 0.56%
Return on equity 0.91%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.92
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.78
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.47
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 81.42%
Book value per share (mrq) 1.31
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
